Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 stu...
by Swain, Sandra M. (Author)
, Miles, David (Author)
, Kim, Sung-Bae (Author)
, Im, Young-Hyuck (Author)
, Im, Seock-Ah (Author)
, Semiglazov, Vladimir (Author)
, Ciruelos, Eva (Author)
, Schneeweiss, Andreas (Author)
, Loi, Sherene (Author)
, Monturus, Estefanía (Author)
, Clark, Emma (Author)
, Knott, Adam (Author)
, Restuccia, Eleonora (Author)
, Benyunes, Mark C (Author)
, Cortés, Javier (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource